Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 5/20 | 0.75 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.75 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.75 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.75 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.74 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.74 |
| ▸ | NR4A2 | P43354 | 4/20 | 0.68 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.63 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.63 |
| ▸ | PTPRC | P08575 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.58 |
| ▸ | CASP3 | P42574 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.58 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.58 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.58 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.58 |
| ▸ | ALKBH1 | Q13686 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16507246 | 0.86 | LPAR1 (1.00) | MAOBPARP15PARP14PARP10LPAR1 | |
| SCHEMBL20883219 | 0.86 | PARP10 (1.00) | MAOBPARP15PARP14PARP10LPAR1 | |
| SCHEMBL2087950 | 0.86 | MAOB (1.00) | MAOBPARP15PARP14PARP10LPAR1 | |
| SCHEMBL1654034 | 0.86 | GCK (0.66) | MAOBPARP15PARP14PARP10LPAR1 | |
| SCHEMBL2087299 | 0.84 | MAOB (0.66) | MAOBPARP15PARP14PARP10LPAR1 | |
| SCHEMBL1444069 | 0.83 | MAOB (0.74) | MAOBPARP15PARP14PARP10LPAR1 | |
| SCHEMBL17644774 | 0.82 | MAOB (0.68) | MAOBPARP15PARP14PARP10LPAR1 | |
| SCHEMBL2087038 | 0.82 | NR4A2 (0.61) | MAOBPARP15PARP14PARP10LPAR1 | |
| SCHEMBL1443412 | 0.82 | MAOB (0.68) | MAOBPARP15PARP14PARP10LPAR1 | |
| SCHEMBL711300 | 0.82 | GCK (0.59) | MAOBPARP15PARP14PARP10LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190010129-A1 | Amide derivatives as lysophosphatidic acid receptor antagonists | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2019-01-10 | — | — | US | disclosed |
| US-10100018-B2 | Amide derivatives as lysophosphatidic acid receptor antagonists | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2018-10-16 | — | — | US | disclosed |
| US-9464060-B2 | Compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9464060-B2 | Compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-10-11 | — | — | US | disclosed |
| US-9464060-B2 | Compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-10-11 | — | — | US | disclosed |
| US-20160207880-A1 | AMIDE DERIVATIVES AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20160207880-A1 | AMIDE DERIVATIVES AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20160207880-A1 | AMIDE DERIVATIVES AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-07-21 | — | — | US | disclosed |
| EP-3036215-A1 | AMIDE DERIVATIVES AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | Takeda Pharmaceutical Company Limited (JP) | 2016-06-29 | — | — | EP | disclosed |
| US-20150057298-A1 | NOVEL COMPOUNDS | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2015-02-26 | — | — | US | disclosed |
| EP-2477964-B1 | Process for preparing alpha-carboxamide derivatives | CONVERGENCE PHARMACEUTICALS (GB) | 2015-02-11 | — | — | EP | disclosed |
| US-8759542-B2 | Process for preparing alpha-carboxamide derivatives | Convergence Pharmaceuticals Limited (GB) | 2014-06-24 | — | — | US | disclosed |
| US-8759542-B2 | Process for preparing alpha-carboxamide derivatives | Convergence Pharmaceuticals Limited (GB) | 2014-06-24 | — | — | US | disclosed |
| US-8759542-B2 | Process for preparing alpha-carboxamide derivatives | Convergence Pharmaceuticals Limited (GB) | 2014-06-24 | — | — | US | disclosed |
| US-20120226053-A1 | PROCESS FOR PREPARING ALPHA-CARBOXAMIDE DERIVATIVES | Convergence Pharmaceuticals Limited | 2012-09-06 | — | — | US | disclosed |
| US-20120226053-A1 | PROCESS FOR PREPARING ALPHA-CARBOXAMIDE DERIVATIVES | Convergence Pharmaceuticals Limited | 2012-09-06 | — | — | US | disclosed |
| US-20120226053-A1 | PROCESS FOR PREPARING ALPHA-CARBOXAMIDE DERIVATIVES | Convergence Pharmaceuticals Limited | 2012-09-06 | — | — | US | disclosed |
| EP-2477964-A1 | PROCESS FOR PREPARING ALPHA-CARBOXAMIDE DERIVATIVES | Convergence Pharmaceuticals Limited (GB) | 2012-07-25 | — | — | EP | disclosed |
| WO-2011029762-A1 | PROCESS FOR PREPARING ALPHA-CARBOXAMIDE DERIVATIVES | Convergence Pharmaceuticals Limited (GB) | 2011-03-17 | — | — | WO | disclosed |
| WO-2011029762-A1 | PROCESS FOR PREPARING ALPHA-CARBOXAMIDE DERIVATIVES | Convergence Pharmaceuticals Limited (GB) | 2011-03-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10100018-B2 | Amide derivatives as lysophosphatidic acid receptor antagonists | LPAR1, LPAR2, LPAR3 | MAOB 1739/4885PARP15 1074/4885PARP14 1285/4885 |
| US-20120226053-A1 | PROCESS FOR PREPARING ALPHA-CARBOXAMIDE DERIVATIVES | CBR1, CBR3, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 | MAOB 2874/4885PARP15 1714/4885PARP14 2271/4885 |
| US-20190010129-A1 | Amide derivatives as lysophosphatidic acid receptor antagonists | LPAR1, LPAR2, LPAR3 | MAOB 1490/4885PARP15 1028/4885PARP14 1210/4885 |
| US-20160207880-A1 | AMIDE DERIVATIVES AS LYSOPHOSPHATIDIC ACID RECEPTOR ANTAGONISTS | LPAR1, LPAR2, LPAR3 | MAOB 1739/4885PARP15 1074/4885PARP14 1285/4885 |
| US-20150057298-A1 | NOVEL COMPOUNDS | F12, C1R, CHRM1 | MAOB 270/4885PARP15 1172/4885PARP14 1122/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.